Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kotev

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2023
Molecular Dynamics and Other HPC Simulations for Drug DiscoveryMartin Kotev, Constantino Diaz Gonzalez
Bioorganic & Medicinal Chemistry|August 23, 2016
Challenges of docking in large, flexible and promiscuous binding sitesMartin Kotev, Robert Soliva, Modesto Orozco
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2020
User-Friendly Quantum Mechanics: Applications for Drug DiscoveryMartin Kotev, Laurie Sarrat, Constantino Diaz Gonzalez
Biophysical Journal|January 8, 2015
Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniquesMartin Kotev, Daniel Lecina, Teresa Tarragó, et al.
Journal of Chemical Information and Modeling|July 28, 2018
Pushing the Limits of Computational Structure-Based Drug Design with a Cryo-EM Structure: The Ca<sup>2+</sup> Channel α2δ-1 Subunit as a Test CaseMartin Kotev, Rosalia Pascual, Carmen Almansa, et al.
Journal of Computer-Aided Molecular Design|November 20, 2021
Fine tuning for success in structure-based virtual screeningEmilie Pihan, Martin Kotev, Obdulia Rabal, et al.
Chembiochem : a European Journal of Chemical Biology|February 27, 2016
Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational DynamicsAbraham López, Fátima Herranz-Trillo, Martin Kotev, et al.
Journal of Chemical Information and Modeling|August 2, 2017
Inhibition of Human Enhancer of Zeste Homolog 2 with Tambjamine AnalogsMartin Kotev, Pilar Manuel-Manresa, Elsa Hernando, et al.
Chemmedchem|November 11, 2015
Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth FactorNúria Bayó-Puxan, Ricard Rodríguez-Mias, Michael Goldflam, et al.
Scientific Reports|November 2, 2017
Combating virulence of Gram-negative bacilli by OmpA inhibitionXavier Vila-Farrés, Raquel Parra-Millán, Viviana Sánchez-Encinales, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2023
Molecular Dynamics and Other HPC Simulations for Drug DiscoveryMartin Kotev, Constantino Diaz Gonzalez
Bioorganic & Medicinal Chemistry|August 23, 2016
Challenges of docking in large, flexible and promiscuous binding sitesMartin Kotev, Robert Soliva, Modesto Orozco
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2020
User-Friendly Quantum Mechanics: Applications for Drug DiscoveryMartin Kotev, Laurie Sarrat, Constantino Diaz Gonzalez
Biophysical Journal|January 8, 2015
Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniquesMartin Kotev, Daniel Lecina, Teresa Tarragó, et al.
Journal of Chemical Information and Modeling|July 28, 2018
Pushing the Limits of Computational Structure-Based Drug Design with a Cryo-EM Structure: The Ca<sup>2+</sup> Channel α2δ-1 Subunit as a Test CaseMartin Kotev, Rosalia Pascual, Carmen Almansa, et al.
Journal of Computer-Aided Molecular Design|November 20, 2021
Fine tuning for success in structure-based virtual screeningEmilie Pihan, Martin Kotev, Obdulia Rabal, et al.
Chembiochem : a European Journal of Chemical Biology|February 27, 2016
Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational DynamicsAbraham López, Fátima Herranz-Trillo, Martin Kotev, et al.
Journal of Chemical Information and Modeling|August 2, 2017
Inhibition of Human Enhancer of Zeste Homolog 2 with Tambjamine AnalogsMartin Kotev, Pilar Manuel-Manresa, Elsa Hernando, et al.
Chemmedchem|November 11, 2015
Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth FactorNúria Bayó-Puxan, Ricard Rodríguez-Mias, Michael Goldflam, et al.
Scientific Reports|November 2, 2017
Combating virulence of Gram-negative bacilli by OmpA inhibitionXavier Vila-Farrés, Raquel Parra-Millán, Viviana Sánchez-Encinales, et al.
Pageof 2